These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2011-006313-33 Phase II, multicenter, open study , first line treatment of intermittenty administered Erlotinib plus Carboplatin, paclitaxel and bebacizumab in patients with advanced none small and none squamous l... bad-data